IP Library Granted Patent US 11,105,812
Granted Patent B2
US 11,105,812 · App. 15/461,034 · Granted Aug 31, 2021

Identifying peptides at the single molecule level

Inventors: Edward Marcotte (Austin, TX); Jagannath Swaminathan (Austin, TX); Andrew Ellington (Austin, TX); Eric V. Anslyn (Austin, TX)
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
G01N33/6824G01N2570/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,105,812
App. No.
15/461,034
Granted
Aug 31, 2021
Kind
B2
Abstract

The present invention relates to methods for identifying amino acids in peptides. In one embodiment, the present invention contemplates labeling the N-terminal amino acid with a first label and labeling an internal amino acid with a second label. In some embodiments, the labels are fluorescent labels. In other embodiments, the internal amino acid is lysine. In other embodiments, amino acids in peptides are identified based on the fluorescent signature for each peptide at the single molecule level.

Claims (21)

1. A method for peptide sequencing, comprising:

a) providing a plurality of immobilized peptides on a solid support, wherein amino acids of an amino acid type of said plurality of immobilized peptides comprise a label, wherein said amino acid type is at least one of lysine, cysteine, histidine, and tyrosine;

b) contacting N-terminal amino acids of said plurality of immobilized peptides with an Edman degradation agent under conditions sufficient to remove said N-terminal amino acids of said plurality of immobilized peptides;

c) detecting said label on amino acids of said amino acid type of said plurality of immobilized peptides; and

d) repeating b) and c) one or more times to sequence said plurality of immobilized peptides.

2. The method of claim 1 , wherein said label is a fluorescent molecule.

3. The method of claim 2 , wherein said detecting comprises measuring a fluorescence intensity of said fluorescent molecule.

4. The method of claim 1 , wherein said plurality of immobilized peptides are immobilized to said solid support via internal cysteine residues.

5. The method of claim 1 , wherein said detecting comprises measuring an intensity of light emitted from said label.

6. The method of claim 1 , wherein d) comprises repeating b) and c) at least two times.

7. The method of claim 1 , wherein an N-terminal amino acid of an immobilized peptide of said plurality of immobilized peptides is of said amino acid type, wherein said immobilized peptide comprises at least one amino acid of said amino acid type separate from said N-terminal amino acid, and wherein in b) said N-terminal amino acid is removed.

8. The method of claim 1 , wherein a pattern of degradation that coincides with a reduction of signal emitted by said label is unique to at least one peptide of said plurality of immobilized peptides.

9. The method of claim 8 , wherein the pattern is compared to a proteome of an organism to identify said at least one peptide.

10. The method of claim 1 , further comprising, prior to b), contacting said plurality of immobilized peptides with an additional labeling agent under conditions sufficient to generate an additional label on amino acids of another amino acid type in said plurality of immobilized peptides.

11. The method of claim 1 , wherein all amino acids of said amino acid type in said plurality of immobilized peptides comprise said label.

12. The method of claim 1 , further comprising, prior to a), (i) providing a sample comprising a plurality of peptides, (ii) contacting said plurality of peptides with a labeling agent under conditions sufficient to generate said label on said amino acids of said amino acid type, and (iii) immobilizing said plurality of peptides on said solid support, thereby providing said plurality of immobilized peptides.

13. The method of claim 1 , wherein said amino acid type is cysteine.

14. The method of claim 1 , wherein said amino acid type is histidine.

15. The method of claim 1 , wherein said amino acid type is tyrosine.

16. The method of claim 1 , wherein said Edman degradation agent is an isothiocyanate derivative selected from the group consisting of phenyl isothiocyanate, fluorescein isothiocyanate, cyanine isothiocyanate, and rhodamine isothiocyanate.

17. The method of claim 1 , wherein in c) an absence or a reduction in signal intensity indicates that said label has been removed.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042776/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2017
From: MARCOTTE, EDWARD; SWAMINATHAN, JAGANNATH; ELLINGTON, ANDREW; ANSLYN, ERIC
To: BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 042002/0417 →
Continuity (4)
Continuation 14128247
Provisional Application 61500525 · Jun 23, 2011
Related Publication 20170242024A1 · Aug 24, 2017
Related Publication 20210018511A9 · Jan 21, 2021
Cited By (4)
US 12,196,760 US 12,379,381 US 12,498,379 US 12,578,345